Rankings
▼
Calendar
ONC Q1 2025 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena
ONC
BeOne Medicines Ltd.
$33B
Q1 2025 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$1.1B
+48.6% YoY
Gross Profit
$952M
85.2% margin
Operating Income
$11M
1.0% margin
Net Income
$1M
0.1% margin
EPS (Diluted)
$0.01
QoQ Revenue Growth
-0.9%
Cash Flow
Operating Cash Flow
$44M
Free Cash Flow
-$72M
Stock-Based Comp.
$95M
Balance Sheet
Total Assets
$5.8B
Total Liabilities
$2.3B
Stockholders' Equity
$3.5B
Cash & Equivalents
$2.5B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.1B
$752M
+48.6%
Gross Profit
$952M
$627M
+51.9%
Operating Income
$11M
-$261M
+104.2%
Net Income
$1M
-$251M
+100.5%
Revenue Segments
Product
$1.4B
99%
Collaboration
$9M
1%
Geographic Segments
UNITED STATES
$567M
51%
CHINA
$400M
36%
Europe
$119M
11%
All Other Countries Except China And United States Of America
$32M
3%
← FY 2025
All Quarters
Q2 2025 →